000 01310 a2200409 4500
005 20250515132249.0
264 0 _c20081118
008 200811s 0 0 eng d
022 _a1555-8576
024 7 _a10.4161/cbt.7.7.6537
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWheeler, D L
245 0 0 _aErbB4 targeting approaches for prostate cancer treatment.
_h[electronic resource]
260 _bCancer biology & therapy
_cJul 2008
300 _a1095-7 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xchemistry
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aCell Survival
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aErbB Receptors
_xchemistry
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aModels, Biological
650 0 4 _aProstatic Neoplasms
_ximmunology
650 0 4 _aReceptor, ErbB-4
700 1 _aRangnekar, Vivek M
700 1 _aSchwarze, S R
773 0 _tCancer biology & therapy
_gvol. 7
_gno. 7
_gp. 1095-7
856 4 0 _uhttps://doi.org/10.4161/cbt.7.7.6537
_zAvailable from publisher's website
999 _c18171467
_d18171467